Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration

References

• BosquillonCLombryCPreatVVanbeverRInfluence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performanceJ Control Release200170332933911182203
   PubMed Web of Science ®Google Scholar
• VarshosazJTaymouriSHamishehkarHFabrication of polymeric nanoparticles of poly(ethylene-co-vinyl acetate) coated with chitosan for pulmonary delivery of carvedilolJ Appl Polym Sci20141311396943969139698
   Web of Science ®Google Scholar
• AliAMAAbdelrahimMEAModeling and optimization of terbutaline emitted from a dry powder inhaler and influence on systemic bioavailability using data mining technologyJ Pharm Innov201493847
   Web of Science ®Google Scholar
• MansourHMRheeYSWuXNanomedicine in pulmonary deliveryInt J Nanomed20094299319
   PubMed Web of Science ®Google Scholar
• XiJLongestPWEffects of oral airway geometry characteristics on the diffusional deposition of inhaled nanoparticlesJ Biomech Eng2008130101100818298184
   PubMed Web of Science ®Google Scholar
• SalemHAbdelrahimMEidKASharafMNanosized rods agglomerates as a new approach for formulation of a dry powder inhalerInt J Nanomed20116311320
   PubMed Web of Science ®Google Scholar
• AbdelbaryAALiXEl-NabarawiMElassasyAJastiBComparison of nanomilling and coprecipitation on the enhancement of in vitro dissolution rate of poorly water-soluble model drug aripiprazolePharm Dev Technol201419449150023731085
   PubMed Web of Science ®Google Scholar
• KeckCMMullerRHDrug nanocrystals of poorly soluble drugs produced by high pressure homogenisationEur J Pharm Biopharm200662131616129588
   PubMed Web of Science ®Google Scholar
• Van EerdenbrughBVan den MooterGAugustijnsPTop-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid productsInt J Pharm20083641647518721869
   PubMed Web of Science ®Google Scholar
• de WaardHHinrichsWLFrijlinkHWA novel bottom-up process to produce drug nanocrystals: controlled crystallization during freeze-dryingJ Control Release2008128217918318423767
   PubMed Web of Science ®Google Scholar
• ZhangHXWangJXZhangZBLeYShenZGChenJFMicronization of atorvastatin calcium by antisolvent precipitation processInt J Pharm20093741–210611319446766
   PubMed Web of Science ®Google Scholar
• MichalEMMargaretAHKeithPJOWIRDrug nanoparticles by anti-solvent precipitation mixing energyLangmuir2006228951895917014140
   PubMed Web of Science ®Google Scholar
• AbbasiSAfrasiabiAZarchiAAKFaramarziMATavoosidanaGAmaniAPreparation and optimization of N-acetylcysteine nanosuspension through nanoprecipitation: an artificial neural networks studyJ Pharm Innov20149115120
   Web of Science ®Google Scholar
• RoweRCRobertsRJIntelligent Software for Product FormulationLondonTaylor and Francis1998
   Google Scholar
• SunYPengYChenYShuklaAJApplication of artificial neural networks in the design of controlled release drug delivery systemsAdv Drug Deliv Rev20035591201121512954199
   PubMed Web of Science ®Google Scholar
• BasDBoyaciIModeling and optimization II: comparison of estimation capabilities of response surface methodology with artificial neural networks in a biochemical reactionJ Food Eng2007783846854
   Web of Science ®Google Scholar
• ChenYThosarSSForbessRAKemperMSRubinovitzRLShuklaAJPrediction of drug content and hardness of intact tablets using artificial neural network and near-infrared spectroscopyDrug Dev Ind Pharm200127762363111694009
   PubMed Web of Science ®Google Scholar
• HussainASYuXQJohnsonRDApplication of neural computing in pharmaceutical product developmentPharm Res1991810124812521796042
   PubMed Web of Science ®Google Scholar
• AksuBParadkarAde MatasMOzerOGuneriTYorkPQuality by design approach: application of artificial intelligence techniques of tablets manufactured by direct compressionAAPS Pharm Sci Tech201213411381146
   Web of Science ®Google Scholar
• LiuDXuHTianBFabrication of carvedilol nanosuspensions through the anti-solvent precipitation-ultrasonication method for the improvement of dissolution rate and oral bioavailabilityAAPS Pharm Sci Tech2012131295304
   PubMed Web of Science ®Google Scholar
• KramerBKRessKMErleyCMRislerTPharmacokinetic and blood pressure effects of carvedilol in patients with chronic renal failureEur J Clin Pharmacol199243185881505616
   PubMed Web of Science ®Google Scholar
• von MollendorffEReiffKNeugebauerGPharmacokinetics and bioavailability of carvedilol, a vasodilating beta-blockerEur J Clin Pharmacol19873355115133428345
   PubMed Web of Science ®Google Scholar
• DeckerSGabelR-dLapotnikoffJWirlAZimmermannIInventors; assigneeCarvedilol-lipophilic solutionsUnited States patent US200100369602001
   Google Scholar
• WenXTanFJingZLiuZPreparation and study the 1:2 inclusion complex of carvedilol with beta-cyclodextrinJ Pharm Biomed Anal200434351752315127807
   PubMed Web of Science ®Google Scholar
• WeiLLiJGuoLInvestigations of a novel self-emulsifying osmotic pump tablet containing carvedilolDrug Dev Ind Pharm200733999099817891586
   PubMed Web of Science ®Google Scholar
• PlaninsekOKovacicBVrecerFCarvedilol dissolution improvement by preparation of solid dispersions with porous silicaInt J Pharm20114061–2414821219991
   PubMedGoogle Scholar
• ElsayedIAbdelbaryAAElshafeeyAHNanosizing of a poorly soluble drug: technique optimization, factorial analysis, and pharmacokinetic study in healthy human volunteersInt J Nanomed2014929432953
   PubMed Web of Science ®Google Scholar
• DuretCWauthozNSebtiTVanderbistFAmighiKNew inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosisInt J Nanomed2012754755489
   PubMed Web of Science ®Google Scholar
• AliAAAliAMOptimization of propranolol HCl release kinetics from press coated sustained release tabletsPharm Dev Technol20131851238124622582904
   PubMed Web of Science ®Google Scholar
• RoweRCColbournEAData mining methods in pharmaceutical formulationBalakinKVPharmaceutical Data Mining: Approaches and Applications for Drug DiscoveryHoboken, NJJohn Wiley & Sons, Inc2009401421
   Google Scholar
• PlumbAPRoweRCYorkPBrownMOptimisation of the predictive ability of artificial neural network (ANN) models: a comparison of three ANN programs and four classes of training algorithmEur J Pharm Sci200525439540515893460
   PubMed Web of Science ®Google Scholar
• ThakkarHPPatelBVThakkarSPDevelopment and characterization of nanosuspensions of olmesartan medoxomil for bioavailability enhancementJ Pharm Bioallied Sci20113342643421966165
   PubMedGoogle Scholar
• GaoBWangJWangDA novel preparation method for drug nanocrystals and characterization by ultrasonic spray-assisted electrostatic adsorptionInt J Nanomed2013839273935
   PubMed Web of Science ®Google Scholar
• SunJWangFSuiYEffect of particle size on solubility, dissolution rate, and oral bioavailability: evaluation using coenzyme Q10 as naked nanocrystalsInt J Nanomed201275733
   PubMed Web of Science ®Google Scholar
• RahmanZZidanASKhanMARisperidone solid dispersion for orally disintegrating tablet: its formulation design and non-destructive methods of evaluationInt J Pharm20104001495820801200
   PubMedGoogle Scholar
• HecqJrmDeleersMFanaraDVranckxHAmighiKPreparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipineInt J Pharm2005299116717715996838
   PubMedGoogle Scholar
• RajuVMurthyKVDevelopment and validation of new discriminative dissolution method for carvedilol tabletsIndian J Pharm Sci201173552753622923865
   PubMed Web of Science ®Google Scholar
• CostaPSousa LoboJMModeling and comparison of dissolution profilesEur J Pharm Sci200113212313311297896
   PubMed Web of Science ®Google Scholar
• British PharmacopoeiaPreparations for inhalation. Aerodynamic assessment of fine particles-fine particle dose and particle size distribution (Ph. Eur. method 2.9.18)British Pharmacopoeia4LondonBritish Pharmacopoeia2005A277A290
   Google Scholar
• European Pharmacopeia2918: Preparations for inhalation: aerodynamic assessment of fine particlesEuropean PharmacopeiaStrasbourg, FranceCouncil of Europe2002209217
   Google Scholar
• United States PharmacopeiaAerosols, nasal sprays, metered dose inhalers and dry powder inhalersThe United States pharmacopeia 28 [and] The national formulary 23Rockville, MDThe Board of Trustees200523592377
   Google Scholar
• Basaveswara RaoMVNagendrakumarAVDYedukondaluMRamanBVNew validated rp–hplc method for the estimation of carvedilol in pharmaceutical formulationInt J Pharm Sci201242253358
   Google Scholar
• Copley Scientific LimitedCopley Scientific CatalogueNottinghamCopley Scientific Limited2015 Available from: http://www.copleyscientific.com/files/ww/brochures/Inhaler%20Brochure%202015_Rev4%20_Low%20Res_pdfAccessed September 17, 2015
   Google Scholar
• Van OortMIn vitro testing of dry powder inhalersAerosol Sci Tech1995224364373
   Web of Science ®Google Scholar
• GhaffariAAbdollahiHKhoshayandMBozchalooiISDadgarARafiee-TehraniMPerformance comparison of neural network training algorithms in modeling of bimodal drug deliveryInt J Pharm2006327112613816959449
   PubMed Web of Science ®Google Scholar
• AghajaniMShahverdiARAmaniAThe use of artificial neural networks for optimizing polydispersity index (PDI) in nanoprecipitation process of acetaminophen in microfluidic devicesAAPS Pharm Sci Tech201213412931301
   Web of Science ®Google Scholar
• SchroenCGPHCohen StuartMAMaarschalkKVvan der PadtAvan’t RietKInfluence of preadsorbed block copolymers on protein adsorption: Surface properties, layer thickness, and surface coverageLangmuir19951130683074
   Web of Science ®Google Scholar
• NejadnikMROlssonALSharmaPKvan der MeiHCNordeWBusscherHJAdsorption of pluronic F-127 on surfaces with different hydrophobicities probed by quartz crystal microbalance with dissipationLangmuir200925116245624919374344
   PubMed Web of Science ®Google Scholar
• LiJ-TCaldwellKDRapoportNSurface properties of pluronic-coated polymeric colloidsLangmuir19941044754482
   Web of Science ®Google Scholar
• BesheerAVogelJGlanzDKresslerJGrothTMaderKCharacterization of PLGA nanospheres stabilized with amphiphilic polymers: hydrophobically modified hydroxyethyl starch vs pluronicsMol Pharm20096240741519718794
   PubMed Web of Science ®Google Scholar
• AbdelbaryAALiXEl-NabarawiMElassasyAJastiBEffect of fixed aqueous layer thickness of polymeric stabilizers on zeta potential and stability of aripiprazole nanosuspensionsPharm Dev Technol201318373073523033924
   PubMed Web of Science ®Google Scholar
• BendasERAbdelbaryAAInstantaneous enteric nanoencapsulation of omeprazole: pharmaceutical and pharmacological evaluationInt J Pharm20144681–29710424746414
   PubMedGoogle Scholar
• Al-MahallawiAMAbdelbaryAAAburahmaMHInvestigating the potential of employing bilosomes as a novel vesicular carrier for trans-dermal delivery of tenoxicamInt J Pharm20154851–232934025796122
   PubMed Web of Science ®Google Scholar
• HildesheimJFinogueevSAronhimeJDolitzkyB-ZBen-ValidSKorIInventors; assigneeCarvedilol United States patent US7056942 B22006
   Google Scholar
• RajuAReddyAJSatheeshJJithanAVPreparation and Characterisation of nevirapine oral nanosuspensionsInd J Pharm Sci20147616271
   PubMed Web of Science ®Google Scholar
• Van EerdenbrughBVermantJMartensJASolubility increases associated with crystalline drug nanoparticles: methodologies and significanceMol Pharm2010751858187020822111
   PubMedGoogle Scholar
• KesisoglouFPanmaiSWuYNanosizingoral formulation development and biopharmaceutical evaluationAdv Drug Deliv Rev200759763164417601629
   PubMed Web of Science ®Google Scholar
• DolencAKristlJBaumgartnerSPlaninsekOAdvantages of celecoxib nanosuspension formulation and transformation into tabletsInt J Pharm20093761–220421219426794
   PubMedGoogle Scholar
• MosharrafMCNThe effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugsInt J Pharm19951221–23547
   Web of Science ®Google Scholar
• BisratMCNPhysicochemical aspects of drug release. VIII. The relation between particle size and surface specific dissolution rate in agitated suspensionsInt J Pharm1988471–3223231
   Google Scholar
• NiebergallPJMilosovichGGoyanJEDissolution rate studies. II. Dissolution of particles under conditions of rapid agitationJ Pharm Sci19635223624113938476
   PubMed Web of Science ®Google Scholar
• YangWJohnstonKPWilliamsIII ROComparison of bioavailability of amorphous versus crystalline itraconazole nanoparticles via pulmonary administration in ratsEur J Pharm Biopharm2010751334120102737
   PubMed Web of Science ®Google Scholar
• KaialyWAlhalawehAVelagaSPNokhodchiAEffect of carrier particle shape on dry powder inhaler performanceInt J Pharm20114211122321945739
   PubMedGoogle Scholar
• RattanupatamTSrichanaTBudesonide dry powder for inhalation: effects of leucine and mannitol on the efficiency of deliveryDrug Deliv201421639740524401124
   PubMed Web of Science ®Google Scholar
• PilcerGAmighiKFormulation strategy and use of excipients in pulmonary drug deliveryInt J Pharm2010392111920223286
   PubMedGoogle Scholar